August 2024, Vol 10, No. 8, Pages 1013-1140

This nonrandomized controlled trial assesses whether neoadjuvant modified 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) leads to early control of micrometastasis and improves survival.

This retrospective cohort study quantifies and compares home time for older patients with newly diagnosed acute myeloid leukemia receiving either hypomethylating agents or anthracycline-based chemotherapy.

This randomized clinical trial evaluates the efficacy and safety of transarterial chemoembolization (TACE) plus sorafenib vs TACE alone for patients with recurrent intermediate-stage hepatocellular carcinoma.

This systematic review examines the proportion and quality of postrecurrence treatment among patients in US Food and Drug Administration (FDA) registration trials of anticancer therapy in the neoadjuvant or adjuvant setting.

This cohort study evaluates surveillance outcomes across a wide spectrum of cancer predisposition syndromes in children and young adults.

This diagnostic study of Black patients assesses the false-negative probability and accuracy of ultrasonography-measured endometrial thickness thresholds as triage for endometrial cancer diagnosis.

This cohort study examines the association between the presence of stromal tumor-infiltrating lymphocytes and survival among patients with stage I triple-negative breast cancer (TNBC) for whom chemotherapy may not be beneficial.

This cohort study compares survival of high-risk patients with screen-detected pancreatic cancer with a matched cohort from the Surveillance, Epidemiology, and End Results program.

This study assesses the accuracy of fluorine-18 prostate-specific membrane antigen–1007 positron emission tomography (PET)/computed tomography (CT) compared to multiparametric magnetic resonance imaging (MRI) in locoregional staging of prostate cancer.